
1. adv exp med biol. 2017;959:231-243. doi: 10.1007/978-3-319-55780-9_21.

gene therapy tyrosinemia: potential pitfalls.

carter s(1), doyon y(2).

author information: 
(1)centre hospitalier universitaire de québec research center faculty of
medicine, centre de recherche du chu de québec - université laval 2705, boulevard
laurier, t-3-67, québec, qc, g1v 4g2, canada.
(2)centre hospitalier universitaire de québec research center faculty of
medicine, centre de recherche du chu de québec - université laval 2705, boulevard
laurier, t-3-67, québec, qc, g1v 4g2, canada.
yannick.doyon@crchudequebec.ulaval.ca.

in chapter, intend review gene therapy concepts applied the
potential treatment tyrosinemia parents pediatricians. therefore, 
main objective give general informations comprehensible manner.
considering nature tyrosinemia current state technology, a
particular focus put strategies using viral delivery dna the
liver. light recent development crispr technology the
revival promises previously unavailable therapeutical tools, present
chapter aims presenting date facts potential pitfalls towards an
application metabolic diseases, particular tyrosinemia.

doi: 10.1007/978-3-319-55780-9_21 
pmid: 28755200  [indexed medline]

